#psychiatry | 2 Minute Medicine

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial

September 22, 2025

1. Tasimelteon significantly reduced sleep onset latency from the first night, with improvements maintained over 4 weeks in patients with ...

Children’s hospital visits for suicide ideation and attempts are increasing

Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial

bySiwen Liuand1 others

September 10, 2025

0

1. Compared to standard care, measurement-based care resulted in faster time to response and time to remission among adults with ...

Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia

byAmy Boyleand1 others

January 27, 2025

0

TEV’749 achieved reductions in schizophrenia symptoms, as measured by differences in the Positive and Negative Syndrome Scale (PANSS) scores, from ...

#VisualAbstract: Pharmacogenomic testing in antidepressant selection for Major Depressive Disorder reduces prescription of medications with drug-gene interactions

byKeerthana Pasumarthi

July 22, 2022

0

Click to read this study in JAMA

Tag: #psychiatry

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial

Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial

Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia

#VisualAbstract: Pharmacogenomic testing in antidepressant selection for Major Depressive Disorder reduces prescription of medications with drug-gene interactions

Recent Reports